-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

602. Myeloid Oncogenesis: Basic: Poster II

Symposia: Myeloid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Chiharu Ishikawa, BS1,2, Laura Barreyro, PhD2, Avery Sampson, BSc2*, Kathleen Hueneman, BSc2*, Kwangmin Choi, PhD2*, Lyndsey C Bolanos, BSc2*, Andrew Volk, PhD2,3, Kenneth D Greis, PhD1* and Daniel T. Starczynowski, PhD1,2,4

1Department of Cancer Biology, College of Medicine, University of Cincinnati, Cincinnati, OH
2Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3Division of Hematology/Oncology, Cincinati Childrens Hospital Medical Center, Cincinnati, OH
4Department of Pediatrics, University of Cincinnati, Cincinnati, OH

Sydney Fobare1, Chia Sharpe, PhD, BS2, Carolyn Cheney, BS2*, Allison Mullaney, DVM3*, Casie Furby, RVT2*, Marissa Long, BS2*, Jean Truxall1*, Megan Johnstone, PhD2*, Ann-Kathrin Eisfeld, MD1, John C. Byrd, MD4 and Erin Hertlein, PhD2

1Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
2Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
3Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
4University of Cincinnati College of Medicine, Cincinnati, OH

Masayuki Umeda, MD1*, Nicole L. Michmerhuizen, PhD1, Ryan Hiltenbrand, MS1*, Juan M. Barajas, PhD1, Bright Arthur, MS1*, Sherif Abdelhamed, PhD1, Jing Ma, PhD1*, Tamara Westover, BS1*, Jonathan Miller, MD, PhD2, Charles G. Mullighan, MBBS, MD1 and Jeffery M. Klco, MD, PhD1

1Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

Hannah J Uckelmann, PhD, BSc, MSc1, Elena L Haarer2*, Reina Takeda, MD, PhD2*, Eric Wong3*, Christian Marinaccio, PhD4*, Charles Hatton5*, Yanhe Wen3*, Florian Perner, MD6, Masooma Rajput2*, Noa J. C. Antonissen3*, Chun-Wei David Chen, PhD7, Lorenzo Brunetti, MD, PhD8* and Scott A. Armstrong, MD, PhD9,10

1Pediatric Oncology, Dana-Farber Cancer Institute, Brookline, MA
2Dana-Farber Cancer Institute, Boston
3Dana-Farber Cancer Institute, Boston, MA
4Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
5Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
6Klinik und Poliklinik für Innere Medizin C, Universitätsklinikum Greifswald, Greifswald, Germany
7Department of Systems Biology, Beckman Research Institute, City of Hope, Duarte, CA
8Department of Molecular and Clinical Sciences, University Hospital of Ancona, Ancona, PG, Italy
9Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA
10Dana-Faber Cancer Institute, Boston, MA

Tamara Westover, BS1, Sherif Abdelhamed, PhD1, Emily Xiong, MS1*, Michael P Walsh, PhD1*, Jing Ma, PhD1*, Jasmine C. Wong, PhD2, Astrid Behnert, MD3*, Mignon L. Loh, MD4, Kevin M. Shannon, MD2 and Jeffery M. Klco, MD, PhD1

1Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
2Department of Pediatrics, University of California, San Francisco, San Francisco, CA
3Department of Pediatrics, Division of Hematology-Oncology, University of California, San Francisco and Benioff Children's Hospital, San Francisco, CA
4Division of Hematology, Oncology, BMT, and Cellular Therapies, Seattle Children's Hospital, Seattle, WA

Hassan Dakik1,2*, Meaghan Boileau2,3, Samantha Worme4,5*, Selin Jessa4,5*, Isabella Iasenza2,3, Andrea Neumann2*, Yi Ling Sun2,3*, Manon Saby2,3*, Morgan Craig6*, Claudia L Kleinman4,5* and Kolja Eppert1,2

1Department of Pediatrics, McGill University, Montreal, QC, Canada
2Research Institute of the McGill University Health Centre, Montreal, QC, Canada
3Division of Experimental Medicine, McGill University, Montreal, QC, Canada
4Department of Human Genetics, McGill University, Montreal, QC, Canada
5Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, QC, Canada
6Département de mathématiques et de statistique, Université de Montréal, Montréal, QC, Canada

Daniela A Barbieri, BS1, Aristeidis G. Telonis, PhD2,3,4* and Maria Ken E. Figueroa, MD4,5,6,7

1University of Miami Miller School of Medicine, Miami, FL
2Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL
3Dept of Human Genetics, Miller School of Medicine, University of Miami, Miami, FL
4Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
5Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL
6Department of Human Genetics, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
7Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL

Ying Ting Sit1*, Hyun Hyung An1*, Alyssa Gagne2*, Deborah L French, PhD2 and Stella T. Chou, MD1

1Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
2Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA

Shanna M Hogeling, MSc1*, Roos Houtsma2*, Nisha K Van Der Meer, MD1*, Salam A. Assi, PhD3*, Paulynn Chin4*, Alan Cunningham2*, Peter Keane5*, Dominique Sternadt Alexandre Ramos6*, Lieve Oudejans6*, Gerwin A. Huls, MD, PhD7, Constance Bonifer, PhD8* and Jan Jacob Schuringa, PhD1

1Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands
2Experimental Hematology, University Medical Center Groningen, Groningen, NLD
3Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom
4Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, GBR
5University of Birmingham, Birmigham, GBR
6Experimental Hematology, UMCG, Groningen, Netherlands
7University Medical Center, University Groningen, Groningen, GZ, Netherlands
8Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom

Scott E Millman, MD, PhD1, Almudena Chaves-Perez, PhD2*, John P Morris IV, PhD2*, Chi-Chao Chen, MD, PhD2*, Yu-Jui Ho, PhD2*, Sudha Janaki Raman, PhD3*, Jossie J Yashinskie4*, Riccardo Mezzadra, PhD2*, Varun Narendra, MD, PhD5*, Sha Tian, MS2*, Alexandra Wuest2*, Wei Luan, MD2*, Justin R Cross, PhD3*, Lydia WS Finley, PhD4* and Scott W Lowe, PhD2,6*

1Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY
3Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY
4Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Howard Hughes Medical Institute, Chevy Chase, MD

Yanan LI, PhD1*, Wei Yang, Ph.D.2*, Riddhi M Patel1*, Emily B Casey1*, Elisabeth Denby1*, Jonny Mendoza-Castrejon, BS3, Priscilla Rodriguez-Lopez1* and Jeffrey A. Magee, MD, PhD1,2

1Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO
2Department of Genetics, Washington University School of Medicine, Saint Louis, MO
3Department of Pediatrics, Washington University School of Medicine, SAINT LOUIS, MO

Aparna Gopal, MSc1,2*, Derek Tam1*, Ryan J. Stubbins, MD, MSc, FRCPC3, Kieran O'Neill, PhD1*, Marion Shadbolt1*, Deborah Deng1*, Rena Buckstein4 and Aly Karsan, MD1,5

1BC Cancer Research Centre, Canada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada
2Interdisciplinary Oncology program, University of British Columbia, Vancouver, BC, Canada
3The Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada
4Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Center, Toronto, Canada
5University of British Columbia, Vancouver, BC, Canada

Aintzane Diaz-Mazkiaran, MSc1*, Jesús De la Fuente, MSc2*, Guillermo Serrano, BSc3,4*, Paula Garcia-Olloqui, PhD5*, Nerea Berastegui6*, Marina Ainciburu, MSc6,7*, Ana Alfonso Pierola, MD3,8,9*, Amaia Vilas-Zornoza, PhD10*, Patxi San Martin-Uriz, PhD11*, Jose Maria Lamo De Espinosa12*, Mikel San Julián13*, Pamela Acha14*, Francesc Solé, PhD15, Tamara Jimenez16*, Félix López Cadenas, MD17*, Maria Diez-Campelo, MD18*, Antonieta Molero, MD19*, Maria Julia Montoro, MD, PhD20*, David Valcarcel, MD, PhD21*, Teresa Ezponda22*, Mikel Hernáez, PhD4* and Felipe Prosper, MD23*

1Computational Biology Program, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, IDISNA, Pamplona, Spain
2TECNUN School of Engineering, University of Navarra, San Sebastian, 20018, Spain., San Sebastian, Spain
3Navarra Institute for Health Research (IdiSNA), Pamplona, Spain
4Computational Biology Program, Cima Universidad de Navarra, Pamplona, Spain
5Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, IDISNA, Pamplona, Spain
6Hematology/Oncology, CIMA Universidad de Navarra, IdISNA, Pamplona, Spain
7Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Pamplona, Spain
8Hematology and Cell Therapy Department, Clínica Universidad de Navarra, Pamplona, Spain
9Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
10Hemato-Oncology Program, Cima Universidad de Navarra, Pamplona, Spain
11Hematology-Oncology Program, Universidad de Navarra, CIMA, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
12Clinica Universidad De Navarra, Pamplona, ESP
13Clínica Universidad de Navarra, Pamplona, Spain
14MDS Research Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Institut Català d’Oncologia-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain
15MDS Group. Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
16Department of Hematology. Salamanca-IBSAL university hospital, Salamanca, Spain
17Hematology, Hospital Universitario de Salamanca-IBSAL, Salamanca, España., Salamanca, Spain
18Department of Hematology. Salamanca-IBSAL university hospital, Salamanca, salamanca, Spain
19Department of Hematology, University Hospital Vall d’Hebron, University Autonoma of Barcelona (UAB), Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
20Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), BARCELONA, Spain
21Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain
22Department of Oncology-Hematology, Centro de Investigación Médica Aplicada (CIMA), Navarra university-IDISNA. Centro de Investigación Biomédica en Red de Cáncer, CIBERONC. Clínica Universidad de Navarra, Pamplona, Spain
23Department of Oncology-Hematology, Centro de Investigación Médica Aplicada (CIMA), Navarra university-IDISNA. Centro de Investigación Biomédica en Red de Cáncer, CIBERONC. Clínica Universidad de Navarra, Pamplona, Navarra, Spain

Jing Xu, MD1*, Ailing Zhong2*, Chong Chen, PhD2*, Yu Liu, PhD2* and Ting Niu1

1Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
2State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center, Chengdu, China

Rahel Fitzel1*, Sarah Brüstl1*, Fulya Korkmaz1*, Barbara Mankel2*, Estelle Erkner1*, Hildegard Keppeler1*, Claudia Lengerke, MD3, Dominik Schneidawind1* and Corina Schneidawind1*

1Department of Internal Medicine II, University Hospital Tuebingen, Tuebingen, Germany
2Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany
3Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany

Casey D.S. Katerndahl, PhD1, Olivia R.S. Rogers, B.S.2*, Sai Mukund Ramakrishnan, MS3*, Christopher A Miller, PhD4*, Nichole M Helton5,6*, Mieke Hoock7* and Timothy J. Ley, MD8

1Department of Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University in St. Louis School of Medicine, Saint Louis, MO
2Washington University in St. Louis, St. Louis
3Department of Medicine/Division of Oncology, Washington University School of Medicine, Saint Louis, MO
4Department of Medicine, Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO
5Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO
6Washington University in Saint Louis, St. Louis, MO
7Washington University St Louis, Saint Louis, MO
8Department of Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University School of Medicine, St. Louis, MO

Christopher Peter Mill, PhD, BA1, Warren C. Fiskus, BSc, PhD2, John A. Davis3*, Kaberi Das4*, Christine E Birdwell, PhD3*, Tapan M. Kadia, MD5, Koji Sasaki, MD6, Koichi Takahashi, MD, PhD7, Courtney D. DiNardo, MD, MSCE6, Sanam Loghavi, MD8, Naval Daver, MD6 and Kapil N. Bhalla, MD6

1MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
3The University of Texas MD Anderson Cancer Center, Houston, TX
4UT MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
8Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Lashanale Wallace, PhD1, Ana Leal-Cervantes, PhD1*, Amina Metidji, PhD1*, Jacquelyn Myers1*, Chandra Rolle2*, Heather Tillman, DVM, PhD3* and Esther A. Obeng, MD, PhD1

1St. Jude Children's Research Hospital, Memphis, TN
2St. Jude Children's Research Hospital, Memphis
3Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN

Fanny C Gonzales, MD, PhD1,2, Shan Lin, PhD1,2, Delan Khalid1*, Jana M Ellegast, MD1,2, Gabriela Alexe, PhD1,2* and Kimberly Stegmaier, MD1,2

1Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA
2Broad Institute of MIT and Harvard, Cambridge, MA

Theodoros Karantanos, MD, PhD1, Christopher Esteb2*, Patric Teodorescu, M.D.3*, Brandy Perkins4*, Ilias Christodoulou, MD5, Stamatia Vorri, M.D.2*, Trivikram Rajkhowa2*, William Brian Dalton, MD, PhD6, Gabriel Ghiaur, MD, PhD7 and Richard J. Jones, MD4

1Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD
2Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore
3Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore
4Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
5Johns Hopkins University School of Medicine, Baltimore, MD
6Johns Hopkins Hospital, Baltimore, MD
7Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD

Shannon E. Conneely, MD1, Jason H. Rogers, MS2*, Rogelio Aguilar2*, Kristen J Kurtz, MD1*, Paul P. Liu, MD, PhD3, Margaret A. Goodell, PhD4, Debananda Pati, PhD5* and Rachel E. Rau, MD1

1Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine/Texas Children's Hospital, Houston, TX
2Baylor College of Medicine, Houston, TX
3Translational and Functional Genomics Branch, National Human Genome Research Institute, NIH, Bethesda, MD
4Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX
5Department of Pediatrics, Baylor College of Medicine, Houston, TX

Alessandra Caroleo1*, Paul Kerbs, Dr.2,3*, Anja Swoboda, MSc4*, Lucas Wange5*, Stephanie Heinzlmeir, Dr.6*, Yun-Chien Chang6*, Bernhard Küster, PhD7*, Wolfgang Enard, Prof. Dr.8*, Michael von Bergwelt, Prof. Dr.9*, Philipp A. Greif, Prof. Dr.4,10 and Monica Cusan, Dr. med4

1Klinikum Großhadern of the Ludwig Maximilian University (LMU), München, Germany
2German Cancer Research Center (DKFZ), Heidelberg, Germany
3Ludwig Maximilian University of Munich, Munich, Germany
4Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
5Anthropology and Human Genomics, Faculty of Biology, LMU Munich, Martinsried, Germany
6Chair of Proteomics and Bioanalytics, School of Life Science, Weihenstephan, Technical University of Munich, Freising, Germany, Freising, Germany
7Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany
8Anthropology and Human Genomics, LMU Munich, Munich, Germany
9Department of Medicine III, University Hospital, LMU Munich, Germany, München, Germany
10German Cancer Research Center (DKFZ), Heidelberg, Germany, Heidelberg, Germany

Yoon Joon Kim1,2*, Kentson Lam, MD, PhD, BA2, Fanny Zhou, BS, MS2*, Carlo M Ong2*, Jeffrey A. Magee, MD, PhD3 and Robert Signer, PhD2

1Department of Bioengineering, University of California, San Diego, La Jolla, CA
2Moores Cancer Center, University of California, San Diego, La Jolla, CA
3Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO

Keon Collett, MSc1*, Sarada Ketharnathan, PhD2, Sergey V Prykhozhij, PhD2*, Benno C Orr3* and Jason N. Berman, MD4

1Cumming School of Medicine, University of Calgary, Calgary, Canada
2CHEO Research Institute, Ottawa, ON, Canada
3Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
4Department of Pediatrics, CHEO Research Institute, Ottawa, ON, Canada

Sohini Chakraborty, PhD1*, Hidenori Kasahara, MD2*, Iryna Berezniuk, PhD1*, Stephen S. Chung, MD3 and Christopher Y. Park, MD, PhD1

1Department of Pathology, NYU Grossman School of Medicine, New York, NY
2Department of Pathology, NYU Grossman School of Medicine, Tokyo, Japan
3Division of Hematology and Oncology, Department of Internal Medicine, Children's Research Institute, University of Texas Southwestern, Dallas, TX

Rasoul Pourebrahim, MD, PhD1*, Rafael Heinz Montoya, BS1*, Edward Ayoub, PhD1*, Hiroki Akiyama, MD, PhD1*, Natalia Baran, MD, PhD2, Tom Lesluyes3*, Lauren B Ostermann1*, Bin Liu4*, Jo Ishizawa, MD, PhD1, Joseph D. Khoury, MD, FCAP5, Marina Konopleva, MD, PhD6, Peter Van Loo7* and Michael Andreeff, MD, PhD2

1Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Cancer Genomics Laboratory, The Francis Crick Institute, London, United Kingdom
4Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston
5Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
6MD Anderson Cancer Center, Houston, TX
7Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston

Pia Radszuweit1*, Fulya Korkmaz1*, Barbara Mankel2*, Rahel Fitzel1*, Estelle Erkner1*, Hildegard Keppeler1*, Claudia Lengerke, MD3, Dominik Schneidawind1* and Corina Schneidawind1*

1Department of Internal Medicine II, University Hospital Tuebingen, Tuebingen, Germany
2Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany
3Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany

Anna D Chorzalska, PhD1*, John Morgan, PhD2*, Diana O Treaba, MD3*, Damali Simon-Ponte4*, Omonike Oyelola4*, John L Reagan, MD5 and Patrycja M Dubielecka, PhD6

1Signal Transduction Lab, Division of Hematology-Oncology,, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, RI
2Rhode Island Hospital, Providence
3Warren Alpert Medical School at Brown University, Providence, RI
4Warren Alpert Medical School of Brown University/Rhode Island Hospital, Providence
5Division of Hematology/Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI
6Division of Hematology-Oncology, Warren Alpert Medical School of Brown University/Rhode Island Hospital, Providence, RI

Kristina Seiler, MD/PhD1, Mario P. Tschan, PhD2, Carmen Kalbermatter, MSc2*, Tanja Muralt, MSc2*, Tata Nageswara Rao3* and Bruce E. Torbett, PhD4

1Division of Experimental Pathology, Institute of Pathology, University of Bern, Bern, Switzerland
2Institute of Pathology, University of Bern, Bern, Switzerland
3Bern University Hospital, Bern, Switzerland
4Department of Pediatrics, School of Medicine, University of Washington, Seattle, Seattle, WA

Alison E Meyer, PhD1, Sid Rao, MD, PhD1, Cary Stelloh2* and Kirthi Pulakanti2*

1Blood Research Institute, Versiti, Milwaukee, WI
2Versiti-Blood Research Institute, Wauwatosa, WI

Joice Kanefsky, BSc1, Yorrick Jaspers, MSc2*, Esteban Martinez, BSc1*, Jacklyn Huhn, BSc1*, Daniela Di Marcoantonio, PhD3*, Stephan Kemp, PhD2*, David Wiest, PhD1 and Stephen M. Sykes, PhD4

1Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA
2Amsterdam University Medical Centers, Amsterdam, Netherlands
3Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia
4Department of Pediatrics, Washington University, Saint Louis, MO

Jonny Mendoza-Castrejon, BS1, Emily B Casey2*, Elisabeth Denby2*, Riddhi M Patel2* and Jeffrey A. Magee, MD, PhD2

1Department of Pediatrics, Washington University School of Medicine, SAINT LOUIS, MO
2Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO

*signifies non-member of ASH